Tympanostomy tube placement for pressure-sensitive vertigo.
Autor: | Abouzari M; Department of Otolaryngology-Head and Neck Surgery University of California Irvine California USA., Tawk K; Department of Otolaryngology-Head and Neck Surgery University of California Irvine California USA., Nguyen CHH; Department of Otolaryngology-Head and Neck Surgery University of California Irvine California USA., Risbud A; Department of Otolaryngology-Head and Neck Surgery University of California Irvine California USA., Djalilian HR; Department of Otolaryngology-Head and Neck Surgery University of California Irvine California USA.; Department of Biomedical Engineering University of California Irvine California USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Laryngoscope investigative otolaryngology [Laryngoscope Investig Otolaryngol] 2022 Oct 05; Vol. 7 (6), pp. 1987-1991. Date of Electronic Publication: 2022 Oct 05 (Print Publication: 2022). |
DOI: | 10.1002/lio2.860 |
Abstrakt: | Objective: To evaluate tympanostomy tube placement in patients with pressure-sensitive vertigo. Methods: Retrospective case series. Results: Six patients with pressure-sensitive vertigo reported resolution of their vertigo and other vestibular symptoms after placement of the tympanostomy tubes. All recurrences of symptoms were due to either extrusion or plugging of the tubes. All patients fulfilled the criteria for vestibular migraine. None of the patients had superior canal dehiscence on imaging or precedent event that triggered the problem, and all had a negative fistula test. Conclusion: Tympanostomy tube placement should be considered in selected patients with vertigo exacerbated by seemingly small changes in atmospheric pressure (e.g., just prior to thunderstorms, air travel, or travel to the mountains). By eliminating the capability of the tympanic membrane to sense changes in pressure with a tube, patients with pressure-induced vertigo (in the absence of perilymph fistula or superior canal dehiscence) may have relief of their symptoms. Competing Interests: Hamid R. Djalilian holds equity in MindSet Technologies, Elinava Technologies, and Cactus Medical LLC. He is a consultant to NXT Biomedical. The remaining authors declare no conflict of interest. (© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |